Table 1.
Results of laboratory examinations
| Exam | At admission | After 1 year |
|---|---|---|
| AST (13–33 IU/L) | 34 | 23 |
| ALT (6–27 IU/L) | 27 | 16 |
| Total bilirubin (0.2–1.2 mg/dL) | 1.01 | 0.69 |
| Glucose (70–109 mg/dL) | 88 | 92 |
| Albumin (3.8–5.3 g/dL) | 4.1 | 4.2 |
| Prothrombin time (70–140%) | 89 | 98 |
| Anti-HCV (CLEIA) | + | |
| HCV RNA Taq (<1.2 Log IU/mL) | 5.7 | 5.4 |
| Antiaquaporin 4 antibody | − | |
| Antinuclear antibody (<40) | 40 | |
| Homogeneous pattern | + | |
| Anti-SSA (<10) | 35.0 | |
| Anti-SSB (<15) | <5.0 | |
| C-ANCA (<3.5 U/mL) | <3.5 | |
| P-ANCA (<3.5 U/mL) | <1.3 | |
| CSF WBC (/μL) | 1 | |
| CSF protein (mg/dL) | 34 | 2 |
| CSF glucose (mg/dL) | 66 | 57 |
| CSF oligoclonal bands | − | |
| CSF IgG index (<0.73) | 0.49 | |
| CSF MBP (pg/mL) | 40.7 | 1.2 |
| CSF anti-HCV (CLEIA) | + | |
| CSF HCV RNA Taq (<1.2 Log IU/mL) | 2.0 | 1.1 |
+, positive; −, negative; ALT, alanine aminotransferase; Anti -ANCA, antineutrophil cytoplasmic antibody; AST, aspartate aminotransferase; CSF, cerebrospinal fluid; HCV, hepatitis C virus; WBC, white blood cell.